Pascal A Le Corre (Pascal Le Corre)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 13

Top Topics

Hematopoietic Stem Cell

Tyrosine Kinase

Oral Anticoagulants

Top Venues

Hematological oncology

International journal of clinical practice

International journal of clinical pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Gwenolé Loas, Philippe Van de Borne, Gil Darquennes, Pascal A Le Corre
Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Mathilde Bories, Guillaume Bouzillé, Marc Cuggia, Pascal A Le Corre
Drug-Drug Interactions with Oral Anticoagulants as Potentially Inappropriate Medications: Prevalence and Outcomes in Elderly Patients in Primary Care and Hospital Settings. Pharmaceutics 14 (7) (2022)
David Malnoë, Olivier Fardel, Pascal A Le Corre
Involvement of Transporters in Intestinal Drug-Drug Interactions of Oral Targeted Anticancer Drugs Assessed by Changes in Drug Absorption Time. Pharmaceutics 14 (11) (2022)
Gwenolé Loas, Pascal A Le Corre
Comment on 'Comparison of losartan and amlodipine effects on the outcomes of patient with COVID-19 and primary hypertension: A randomised clinical trial'. International journal of clinical practice 75 (12) (2022)
Mathilde Bories, Guillaume Bouzillé, Marc Cuggia, Pascal A Le Corre
Drug-Drug Interactions in Elderly Patients with Potentially Inappropriate Medications in Primary Care, Nursing Home and Hospital Settings: A Systematic Review and a Preliminary Study. Pharmaceutics 13 (2) (2021)
Mathilde Bories, Astrid Bacle, Helene Gilardi, Pascal A Le Corre
Risk of acute kidney injury by initiation of non-steroidal anti-inflammatory drugs in hospitalised patients treated with diuretics and renin-angiotensin-aldosterone system inhibitors. European journal of hospital pharmacy : science and practice (2021)
Aurélie Bannay, Mathilde Bories, Pascal A Le Corre, Christine Riou, Pierre Lemordant, Pascal Van Hille, Emmanuel Chazard, Xavier Dode, Marc Cuggia, Guillaume Bouzillé
Leveraging National Claims and Hospital Big Data: Cohort Study on a Statin-Drug Interaction Use Case. JMIR medical informatics 9 (12) (2021)
Pascal A Le Corre, Gwenolé Loas
Repurposing functional inhibitors of acid sphingomyelinase (fiasmas): an opportunity against SARS-CoV-2 infection? Journal of clinical pharmacy and therapeutics 46 (5) (2021)
Pascal A Le Corre
Prescriptome analytics: an opportunity for clinical pharmacy. International journal of clinical pharmacy 41 (6) (2019)
Lydia Sanchez, Astrid Bacle, Thierry Lamy, Pascal A Le Corre
Potential drug-drug interactions and nephrotoxicity in hematopoietic stem cell transplant adult recipients during bone marrow transplantation unit stay. Cancer chemotherapy and pharmacology 83 (5) (2019)
Camille Morival, Richard Westerlynck, Guillaume Bouzillé, Marc Cuggia, Pascal A Le Corre
Prevalence and nature of statin drug-drug interactions in a university hospital by electronic health record mining. European journal of clinical pharmacology 74 (4) (2017)
Camille Morival, Sitty Oumari, Arthur Lenglet, Pascal A Le Corre
Clinical pharmacokinetics of oral drugs in the treatment of multiple myeloma. Hematological oncology (2017)
Caroline Gay, Delphine Toulet, Pascal A Le Corre
Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy. Hematological oncology 35 (3) (2016)